Select Medical Corp (NYSE:SEM) Quarterly Sentiment Report

Marco Green
December 17, 2017

Sirios Capital Management Limited Partnership reported 207,148 shares or 0.16% of all its holdings. Select Med Hldgs Corp now has $2.23 billion valuation. The stock decreased 0.59% or $0.1 during the last trading session, reaching $16.75. The total number of shares traded in the last 12 months is 1.6 million.

Select Medical (NYSE:SEM) last released its quarterly earnings results on Thursday, November 2nd. It has underperformed by 4.20% the S&P500.

Invesco Ltd increased Immunogen Inc (IMGN) stake by 2522.36% reported in 2017Q2 SEC filing.

Institutional investors now hold around $1.87 billion or 80.3% in SEM stock. Wells Fargo & Co Mn holds 152,889 shares or 0% of its portfolio. The stock decreased 0.20% or $0.015 during the last trading session, reaching $7.585. ImmunoGen, Inc. (NASDAQ:IMGN) has declined 3.49% since December 16, 2016 and is downtrending.

Investors sentiment increased to 1.27 in 2017 Q2. Select Medical Holdings Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Senior Vice President Romberger Scott A has sold 5,000 shares of Select Medical Holdings Corporation (SEM) in trading session dated November 29, 2017.

Several hedge funds have recently made changes to their positions in the company. The institutional investors in our partner's database now have: 104.89 million shares, down from 105.63 million shares in 2017Q1. North Tide Capital Llc who had been investing in Select Med Hldgs Corp for a number of months, seems to be less bullish one the $2.23B market cap company. Piedmont Advsr Ltd Company invested in 23,238 shares. State Board Of Administration Of Florida Retirement Sys accumulated 26,860 shares. Capstone Asset Mngmt has 0.02% invested in Select Medical Holdings Corporation (NYSE:SEM) for 38,170 shares. California Pub Employees Retirement Systems reported 255,600 shares or 0.01% of all its holdings. (NASDAQ:TICC). Citigroup Inc invested in 0% or 676 shares. Wafra Advisory New York accumulated 1.64% or 214,751 shares. Cordasco Network owns 500 shares or 0.01% of their U.S. portfolio. Following the completion of the sale, the insider now owns 168,211 shares of the company's stock, valued at approximately $3,022,751.67.

The practice of treating any and all pullbacks in risk assets as opportunities to accumulate more has become entrenched in global equity markets, especially in the USA, according to analysts at Bank of America Merrill Lynch. Morgan Stanley holds 0% or 246,156 shares. Of those holders, 86 had increased positions amounting to 10 million shares, 70 had decreased positions amounting to 10.3 million shares, and 29 holders have a held position accounting for 85.2 million shares. Amer Intl Gp owns 80,443 shares. Affinity Wealth Management purchased a new stake in shares of Select Medical during the 3rd quarter valued at about $429,000. It worsened, as 3 investors sold TICC Capital Corp. shares while 15 reduced holdings. ValuEngine downgraded shares of Select Medical from a "buy" rating to a "hold" rating in a research note on Monday, October 2nd. Therefore 50% are positive.

According to Select Medical Holdings Corporation's latest 13F filing with the US Securities and Exchange Commission (SEC), institutional ownership is at 78.83%. The firm earned "Outperform" rating on Monday, November 2 by RBC Capital Markets. The company was upgraded on Monday, August 7 by Robert W. Baird. The stock has "Buy" rating by Robert W. Baird on Monday, October 23. Blackrock holds 0.01% of its portfolio in Select Medical Holdings Corporation (NYSE:SEM) for 13.34M shares. Benchmark maintained Select Medical Holdings Corporation (NYSE:SEM) rating on Monday, August 7. As per Friday, March 11, the company rating was maintained by Barclays Capital. JMP Securities upgraded the stock to "Mkt Perform" rating in Tuesday, October 20 report. The firm has "Outperform" rating by RBC Capital Markets given on Thursday, April 28. The share last price represents downtick move of -13.86% in value from company's 52-Week high price and shows 487.04% above change in value from its 52-Week low price. Robert W. Baird set a $25.00 price objective on Select Medical and gave the stock a "buy" rating in a research report on Monday, October 23rd. Therefore 14% are positive. SmartFinancial had 4 analyst reports since August 29, 2016 according to SRatingsIntel. On Wednesday, August 12 the stock rating was upgraded by Zacks to "Hold". Needham has "Buy" rating and $18500 target. For the next year, analysts expect that the company will report sales of $5.18 billion per share. The firm has "Hold" rating by TheStreet given on Friday, October 16. The consensus rating is 2.5, suggesting the market has given up on the stock. Hovde Group maintained SmartFinancial, Inc. (NASDAQ:FB) rating on Thursday, July 27. The stock of CareTech Holdings PLC (LON:CTH) has "Buy" rating given on Tuesday, March 15 by Canaccord Genuity. Finally, Shelton Capital Management acquired a new stake in shares of Select Medical during the second quarter worth about $164,000. It also reduced Powershares Etf Trust (PTF) stake by 245,904 shares and now owns 435,796 shares.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Other reports by Click Lancashire

Discuss This Article